Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	0.17	1.49	0.06	0.74	0.68
Cash & Short-Term Investments	0.17	1.49	0.06	0.74	0.68
Cash Growth	128.20%	2434.12%	-92.06%	8.22%	-
Other Receivables	0.02	0.02	-	-	-
Total Trade Receivables	0.02	0.02	-	-	-
Inventory	-	-	-	0.02	-
Other Current Assets	0.02	0.04	0.02	0.08	0.01
Total Current Assets	0.21	1.55	0.08	0.84	0.69
Net Property, Plant & Equipment	0.3	0.31	0.06	0.22	0.29
Other Intangible Assets	13.94	14.23	15.23	-	-
Other Long-Term Assets	-	-	-	-	0.02
Total Assets	14.45	16.09	15.37	1.05	1
Accounts Payable	0.53	0.42	0.84	0.14	0.03
Accrued Expenses	0	0.01	-	0.01	0
Short-Term Debt	-	-	0.15	-	0.17
Current Portion of Leases	0.06	0.31	0.06	0.06	0.06
Other Current Liabilities	0.15	0.16	0.37	-	-
Total Current Liabilities	0.74	0.89	1.43	0.21	0.26
Long-Term Leases	0.24	-	-	0.06	0.13
Total Long-Term Liabilities	0.24	-	-	0.06	0.13
Total Liabilities	0.97	0.89	1.43	0.28	0.39
Preferred Stock	0	0	0	-	-
Common Stock	0	0	0	0	0
Additional Paid-in Capital	57.53	55.85	33.96	12	2.63
Accumulated Other Comprehensive Income	-0	-0	-0.01	-	-
Retained Earnings	-44.05	-40.65	-20	-11.23	-2.02
Total Common Shareholders' Equity	13.48	15.2	13.5	0.77	0.61
Minority Interest	-0	-0	-0	-	-
Shareholders' Equity	13.47	15.2	13.95	0.77	0.61
Total Liabilities & Equity	14.45	16.09	15.37	1.05	1
Total Debt	0.29	0.31	0.21	0.13	0.35
Net Cash (Debt)	-0.12	1.18	-0.16	0.61	0.33
Net Cash Growth	-	-	-	84.95%	-
Net Cash Per Share	-0.01	0.12	-0.08	0.57	0.46
Book Value	13.48	15.2	13.5	0.77	0.61
Book Value Per Share	1.03	1.51	6.82	0.72	0.85
Tangible Book Value	-0.46	0.97	-1.74	0.77	0.61
Tangible Book Value Per Share	-0.04	0.10	-0.88	0.72	0.85

SEC Filings: 10-K · 10-Q